CONTRATOS ARTICULO 60 LOSU

Contrato

Experience In The Field of On Potential Indications of Molecules That Inhibit Nlrp3 And Potential Techniques To Use In The Design of Drugs That Inhibit Nlrp3.

Financiador: GLENMARK PHARMACEUTICALS LIMITED

Duración del 22 de abril de 2021 al 22 de abril de 2022 (12 meses)

607,50 EUR

De ámbito Internacional (no UE). Con carácter Privado.

Responsable